διαδερμική φεντανύλη

Gabapentin was tested as complementary analgesic in 25 cancer patients in whom pain was not sufficiently controlled by transdermal fentanyl. Neuropathic pain syndrome in these patients consisted of burning pain and allodynia. Gabapentin was administered at a dose of 648±206,4mg, while dosage of transdermal fentanyl was fixed (261±98,1μg/h).

Continue reading
Γλώσσα
Αρχείο άρθρων
Επιλέξτε χρονιά
ATOM Feed
RSS Feed
RDF Feed
Άδεια Creative Commons